Skvarka Jan

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Skvarka Jan's trades of Zentalis Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
15.96
Quantity 79,872 +45.4%
Value US$2,074,517
Transaction date
Proposed sale
Price
305.67
Quantity 49,447
Value US$281,260
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-04 2025-01-31
B Purchase
79,872 +45.4%
15.96
US$2,074,517 		79,872 +45.4% 15.96 US$2,074,517
2023-09-13 2023-09-11
PlS Planned sale
94,922 -23.7%
223.54
US$3,729,284 		94,922 -23.7% 223.54 US$3,729,284
2023-09-11 2023-09-11
PrS Proposed sale
49,447
305.67
US$281,260 		49,447 305.67 US$281,260
2021-05-13 2021-05-12
S Sale
23,802 -100.0%
9.24
US$219,880 		23,802 -100.0% 9.24 US$219,880
2021-05-13 2021-05-11
S Sale
106,698 -100.0%
9.20
US$981,803 		106,698 -100.0% 9.20 US$981,803
2021-01-15 2021-01-14
PlS Planned sale
19,581 -100.0%
15.03
US$294,279 		19,581 -100.0% 15.03 US$294,279
2021-01-15 2021-01-13
PlS Planned sale
5,419 -100.0%
15.04
US$81,508 		5,419 -100.0% 15.04 US$81,508